Operating Expenses Summary of Haw Par Corporation Limited

Haw Par Corporation Limited's latest annual operating expenses in 2023 was 70.87 Million SGD , up 28.43% from previous year.
Haw Par Corporation Limited's latest quarterly operating expenses in 2024 Q2 was 16.59 Million SGD , down 0.0% from previous quarter.
Haw Par Corporation Limited reported a annual operating expenses of 55.18 Million SGD in annual operating expenses 2022, up 12.75% from previous year.
Haw Par Corporation Limited reported a annual operating expenses of 48.94 Million SGD in annual operating expenses 2021, up 40.26% from previous year.
Haw Par Corporation Limited reported a quarterly operating expenses of 16.59 Million SGD for 2024 Q2, down 0.0% from previous quarter.
Haw Par Corporation Limited reported a quarterly operating expenses of 16.28 Million SGD for 2023 Q1, up 51.0% from previous quarter.

Annual Operating Expenses Chart of Haw Par Corporation Limited (2023 - 2001)

Historical Annual Operating Expenses of Haw Par Corporation Limited (2023 - 2001)

Year	Operating Expenses	Operating Expenses Growth
2023	70.87 Million SGD	28.43%
2022	55.18 Million SGD	12.75%
2021	48.94 Million SGD	40.26%
2020	34.89 Million SGD	-42.34%
2019	60.51 Million SGD	-3.13%
2018	62.47 Million SGD	-8.18%
2017	68.04 Million SGD	27.42%
2016	53.39 Million SGD	0.81%
2015	52.97 Million SGD	12.08%
2014	47.26 Million SGD	11.04%
2013	42.56 Million SGD	-8.18%
2012	46.35 Million SGD	19.99%
2011	38.63 Million SGD	423.78%
2010	-11.93 Million SGD	-5.92%
2009	-11.26 Million SGD	39.69%
2008	-18.68 Million SGD	51.16%
2007	-38.24 Million SGD	18.2%
2006	-46.75 Million SGD	-101.04%
2005	-23.25 Million SGD	-7554.49%
2004	312 Thousand SGD	-95.35%
2003	6.71 Million SGD	337.74%
2002	1.53 Million SGD	-92.34%
2001	20.01 Million SGD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	16.59 Million SGD	-7.29%
2024 Q2	16.59 Million SGD	0.0%
2023 Q1	16.28 Million SGD	51.0%
2023 Q4	17.89 Million SGD	6.79%
2023 FY	70.87 Million SGD	28.43%
2023 Q2	16.28 Million SGD	0.0%
2023 Q3	16.76 Million SGD	2.95%
2022 Q4	10.78 Million SGD	0.0%
2022 FY	55.18 Million SGD	12.75%
2022 Q1	14.62 Million SGD	-47.22%
2022 Q2	30.97 Million SGD	111.72%
2022 Q3	10.78 Million SGD	-65.19%
2021 Q1	9.76 Million SGD	9.06%
2021 Q4	27.71 Million SGD	126.55%
2021 Q3	12.23 Million SGD	-44.72%
2021 Q2	22.13 Million SGD	126.65%
2021 FY	48.94 Million SGD	40.26%
2020 Q1	9.67 Million SGD	-8.91%
2020 Q3	3.92 Million SGD	-83.37%
2020 FY	34.89 Million SGD	-42.34%
2020 Q4	8.95 Million SGD	128.3%
2020 Q2	23.58 Million SGD	143.75%
2019 FY	60.51 Million SGD	-3.13%
2019 Q4	10.62 Million SGD	-31.59%
2019 Q3	15.52 Million SGD	10.06%
2019 Q2	14.1 Million SGD	-30.38%
2019 Q1	20.26 Million SGD	54.59%
2018 Q1	17.04 Million SGD	28.28%
2018 Q4	13.1 Million SGD	-18.65%
2018 Q3	16.11 Million SGD	-0.6%
2018 Q2	16.21 Million SGD	-4.87%
2018 FY	62.47 Million SGD	-8.18%
2017 FY	68.04 Million SGD	27.42%
2017 Q4	13.28 Million SGD	-23.36%
2017 Q3	17.33 Million SGD	-5.73%
2017 Q2	18.38 Million SGD	-3.38%
2017 Q1	19.03 Million SGD	141.55%
2016 Q4	7.87 Million SGD	-40.16%
2016 FY	53.39 Million SGD	0.81%
2016 Q3	13.16 Million SGD	-16.16%
2016 Q2	15.7 Million SGD	-5.69%
2016 Q1	16.65 Million SGD	70.44%
2015 FY	52.97 Million SGD	12.08%
2015 Q4	9.76 Million SGD	-29.5%
2015 Q3	13.85 Million SGD	-16.53%
2015 Q2	16.59 Million SGD	30.22%
2015 Q1	12.74 Million SGD	32.02%
2014 Q3	12.07 Million SGD	-13.66%
2014 Q4	9.65 Million SGD	-20.01%
2014 Q1	11.55 Million SGD	21.93%
2014 FY	47.26 Million SGD	11.04%
2014 Q2	13.98 Million SGD	21.02%
2013 Q1	9.82 Million SGD	-84.51%
2013 Q3	11.72 Million SGD	1.5%
2013 Q2	11.54 Million SGD	17.57%
2013 FY	42.56 Million SGD	-8.18%
2013 Q4	9.47 Million SGD	-19.16%
2012 Q1	10.18 Million SGD	-79.85%
2012 Q3	-2.55 Million SGD	89.93%
2012 Q4	63.39 Million SGD	2583.12%
2012 FY	46.35 Million SGD	19.99%
2012 Q2	-25.36 Million SGD	-349.04%
2011 Q4	50.55 Million SGD	431.58%
2011 Q1	9.99 Million SGD	49.25%
2011 Q2	-31.42 Million SGD	-414.36%
2011 FY	38.63 Million SGD	423.78%
2011 Q3	9.51 Million SGD	130.26%
2010 Q2	-23.74 Million SGD	-372.09%
2010 Q4	6.69 Million SGD	285.44%
2010 FY	-11.93 Million SGD	-5.92%
2010 Q3	-3.61 Million SGD	84.79%
2010 Q1	8.72 Million SGD	-12.08%
2009 Q1	6.26 Million SGD	0.0%
2009 Q4	9.92 Million SGD	350.59%
2009 Q3	-3.96 Million SGD	83.14%
2009 Q2	-23.49 Million SGD	-474.89%
2009 FY	-11.26 Million SGD	39.69%
2008 FY	-18.68 Million SGD	51.16%
2007 FY	-38.24 Million SGD	18.2%
2006 FY	-46.75 Million SGD	-101.04%
2005 FY	-23.25 Million SGD	-7554.49%
2004 FY	312 Thousand SGD	-95.35%
2003 FY	6.71 Million SGD	337.74%
2002 FY	1.53 Million SGD	-92.34%
2002 Q2	19.87 Million SGD	0.0%
2002 Q4	24.58 Million SGD	0.0%
2001 FY	20.01 Million SGD	0.0%

Peer Operating Expenses Comparison of Haw Par Corporation Limited

Name	Operating Expenses	Operating Expenses Difference
AstraZeneca PLC	29.57 Billion USD	99.76%
Bristol-Myers Squibb Company PFD CONV 2	17.07 Billion USD	99.585%
CSPC Pharmaceutical Group Limited	2.14 Billion USD	96.699%
Clarus Therapeutics Holdings, Inc.	50.96 Million USD	-39.059%
Novartis AG	24.87 Billion USD	99.715%
PT Kalbe Farma Tbk.	11823.24 Billion USD	99.999%

Global Stocks Search

Haw Par Corporation Limited (HAWPY)

Operating Expenses Summary of Haw Par Corporation Limited

Annual Operating Expenses Chart of Haw Par Corporation Limited (2023 - 2001)

Historical Annual Operating Expenses of Haw Par Corporation Limited (2023 - 2001)

Peer Operating Expenses Comparison of Haw Par Corporation Limited